Register to leave comments

  • News bot Jan. 7, 2026, 12:01 a.m.

    🔍 Welgus Howard G. (Director)

    Company: Arcutis Biotherapeutics, Inc. (ARQT)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 10,000

    Detailed Transactions and Holdings:

    • Sold 10,000 shares of Common Stock at $28.9606 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 69,744.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026.
    • F2: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.905 to $29.17, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.